Literature DB >> 21846212

Early detection of prostate cancer: is screening in general practice justifiable?

Emil L Sigurdsson.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21846212      PMCID： PMC3347959          DOI： 10.3109/02813432.2011.602555

Source DB:  PubMed          Journal:  Scand J Prim Health Care        ISSN： 0281-3432            Impact factor:   2.581


× No keyword cloud information.
  12 in total

Review 1.  Cancer burden in the year 2000. The global picture.

Authors:  D M Parkin; F I Bray; S S Devesa
Journal:  Eur J Cancer       Date:  2001-10       Impact factor: 9.162

2.  Informed participation in cancer screening: the facts are changing, and GPs are going to feel it.

Authors:  Linn Getz; John Brodersen
Journal:  Scand J Prim Health Care       Date:  2010-03       Impact factor: 2.581

3.  Screening for prostate cancer remains controversial.

Authors:  Jennifer R Stark; Lorelei Mucci; Kenneth J Rothman; Hans-Olov Adami
Journal:  BMJ       Date:  2009-09-24

4.  Early diagnosis of cancer--the role of general practice.

Authors:  Peter Vedsted; Frede Olesen
Journal:  Scand J Prim Health Care       Date:  2009       Impact factor: 2.581

5.  Screening and prostate-cancer mortality in a randomized European study.

Authors:  Fritz H Schröder; Jonas Hugosson; Monique J Roobol; Teuvo L J Tammela; Stefano Ciatto; Vera Nelen; Maciej Kwiatkowski; Marcos Lujan; Hans Lilja; Marco Zappa; Louis J Denis; Franz Recker; Antonio Berenguer; Liisa Määttänen; Chris H Bangma; Gunnar Aus; Arnauld Villers; Xavier Rebillard; Theodorus van der Kwast; Bert G Blijenberg; Sue M Moss; Harry J de Koning; Anssi Auvinen
Journal:  N Engl J Med       Date:  2009-03-18       Impact factor: 91.245

Review 6.  Benefits and harms of prostate-specific antigen screening for prostate cancer: an evidence update for the U.S. Preventive Services Task Force.

Authors:  Kenneth Lin; Robert Lipsitz; Therese Miller; Supriya Janakiraman
Journal:  Ann Intern Med       Date:  2008-08-05       Impact factor: 25.391

7.  Lead time and overdiagnosis in prostate-specific antigen screening: importance of methods and context.

Authors:  Gerrit Draisma; Ruth Etzioni; Alex Tsodikov; Angela Mariotto; Elisabeth Wever; Roman Gulati; Eric Feuer; Harry de Koning
Journal:  J Natl Cancer Inst       Date:  2009-03-10       Impact factor: 13.506

8.  Interpreting trends in prostate cancer incidence and mortality in the five Nordic countries.

Authors:  Rune Kvåle; Anssi Auvinen; Hans-Olov Adami; Asa Klint; Eivor Hernes; Bjørn Møller; Eero Pukkala; Hans H Storm; Laufey Tryggvadottir; Steinar Tretli; Rolf Wahlqvist; Elisabete Weiderpass; Freddie Bray
Journal:  J Natl Cancer Inst       Date:  2007-12-11       Impact factor: 13.506

9.  Trends in prostate-specific antigen testing from 1995 through 2004.

Authors:  Wildon R Farwell; Jeffrey A Linder; Ashish K Jha
Journal:  Arch Intern Med       Date:  2007-12-10

10.  Randomised prostate cancer screening trial: 20 year follow-up.

Authors:  Gabriel Sandblom; Eberhard Varenhorst; Johan Rosell; Owe Löfman; Per Carlsson
Journal:  BMJ       Date:  2011-03-31
View more
  2 in total

1.  Milestones in the development of Nordic general practice*.

Authors:  Johann A Sigurdsson
Journal:  Scand J Prim Health Care       Date:  2013-01-22       Impact factor: 2.581

2.  Danish General Practitioners' Use of Prostate-Specific Antigen in Opportunistic Screening for Prostate Cancer: A Survey Comprising 174 GPs.

Authors:  Kasper Jessen; Jens Søndergaard; Pia Veldt Larsen; Janus Laust Thomsen
Journal:  Int J Family Med       Date:  2013-11-19
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.